Superworth

Accendra Health EV/EBIT ACH

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026
58.8×
10-year median
18.3×
Against its 10-year history
90th
percentile: 0 is its lowest day, 100 its highest
10-year range
7.7× to 414×
Peer median
8.2×

Accendra Health's EV/EBIT is 58.8× as of Oct 23, 2026.

That is above its ten-year median of 18.3×, higher than on 90% of days in the last ten years.

Over that time it ranged from 7.7× in Sep 2021 to 414× in Dec 2023.

The median for 7 healthcare stocks of a similar size is 8.2×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far58.8×34.7×82.3×
202535.5×17.5×36.9×
202422.2×21.8×404×
2023387×12.7×414×
202212.8×8.8×17.2×
20219.9×7.7×18.1×
202016.7×14.6×23.9×
201922.4×17.7×24.6×
201820.2×10.9×25.7×
201712.2×10.7×12.9×
201610.8×10.1×15.2×
201514.2×13.0×16.4×
201413.4×10.3×13.4×
201312.1×9.6×12.6×
20129.2×8.0×10.0×
20118.9×8.9×11.5×

Against its peers

Companies in Healthcare nearest Accendra Health's size, closest first, today.

CompanyEV/EBIT
ACHAccendra Health58.8×
NEPHNephros20.5×
ATNMActinium Pharmaceuticals1.2×
APTAlpha Pro Tech8.2×
SPROSpero Therapeutics2.1×
LFVNLifevantage9.6×
ICCCImmucell14.2×
KEQUKewaunee Scientific7.2×
Peer median8.2×

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Accendra Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.